
The Master’s Programme in Biopharmaceuticals is a two-year, full-time on-campus program that focuses on the design, development, and production of pharmaceutical products derived from biological sources. The program combines chemistry, molecular biology, and biotechnology to understand how modern medicines such as antibodies, vaccines, and protein-based drugs are developed and manufactured. Students study topics such as bioprocessing, pharmaceutical chemistry, drug development, and regulatory science.
Graduates develop strong biopharmaceutical expertise, drug development knowledge, and applied laboratory skills, preparing them for careers in pharmaceutical industries, biotechnology companies, research institutions, and regulatory agencies. Uppsala University provides a strong research environment with close links to life science and pharmaceutical innovation sectors.
Semester 1 – Foundations of Biopharmaceuticals
• Introduction to Biopharmaceutical Science
• Drug Development and Biotechnology
• Pharmacology and Biopharmaceuticals
• Research Methods in Biopharmaceuticals
Semester 2 – Advanced Biopharmaceuticals
• Pharmaceutical Biotechnology and Manufacturing
• Biopharmaceuticals in Therapeutics
• Regulatory Affairs in the Pharmaceutical Industry
• Elective Modules in Biopharmaceuticals
Semester 3 – Biopharmaceutical Applications
• Clinical Trials and Biopharmaceuticals
• Biopharmaceutical Quality Control
• Biosimilars and Advanced Biopharmaceutical Products
• Fieldwork/Research Project in Biopharmaceuticals
Semester 4 – Master’s Thesis & Final Project
• Independent Research / Thesis
• Advanced Biopharmaceutical Applications
• Final Presentation & Research Evaluation
Graduates of the Biopharmaceuticals Master’s program can pursue careers in pharmaceutical development, biotechnology, clinical research, and regulatory affairs. With expertise in drug development, protein engineering, and clinical trials, alumni can work as biopharmaceutical researchers, regulatory affairs specialists, clinical trial managers, and biotech consultants. The growing emphasis on biologic drugs and biotechnology-driven treatments ensures strong career prospects for graduates in the rapidly expanding biopharmaceutical industry.
The Biopharmaceuticals program provides students with a comprehensive understanding of the development and production of biologic drugs. Students will learn about protein therapeutics, vaccine development, and regulatory requirements for biopharmaceutical products. The program’s combination of laboratory work, industry projects, and theoretical coursework ensures that graduates are well-prepared to contribute to the biopharmaceutical industry’s cutting-edge research and development efforts.
For further information, please contact the admissions office at:
Phone: +46 18 471 00 00
Email: info@uu.se
Address: Uppsala University, S:t Olofsgatan 10B, 753 11 Uppsala, Sweden